US EditionNeogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Neogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth - Pharmafile
Swedish biotech company, Neogap Therapeutics, has been selected to participate in the EIC Soft-landing Programme for Healthcare and Life Sciences in Boston, US. Alongside other major biotech companies, it will showcase its technology to investors and potential partners, strengthening its presence in the US pharma market. Organised by the European Innovation Council, the EIC Soft-landing […] The post Neogap Therapeutics selected to join EIC Soft-…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
